Live Video Series
The Road to a Vaccine
In Season 2 of The Road to a Vaccine, host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.
Season 2 Special
Vaccines 101: Taking a Look at Phase 3 Clinical Trials
Johnson & Johnson’s Dr. Mathai Mammen, Global Head of R&D, discusses how the company’s new global clinical trial phase will work, how safety is a top priority and why the company has chosen to vaccinate up to 60,000 people in Phase 3.

Recent Johnson & Johnson Initiatives in the Spotlight

Learn more about the company’s latest groundbreaking programs, game-changing innovations and global partnerships—all aimed at helping change the trajectory of health for humanity.
This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.